Join
Live feed
·
INSIDERFilingvia Quantisnow
Viking Therapeutics Inc. logo

Director Rowland Charles A Jr was granted 3,150 shares, increasing direct ownership by 10% to 33,150 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VKTX· Viking Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VKTX (Viking Therapeutics Inc.) and more on Quantisnow.